Health technology assessment of biosimilars worldwide: a scoping review

BACKGROUND: Health technology assessment (HTA) should provide an assessment of a technology’s effects on health and of the related social, economic, organisational and ethical issues. HTA reports on biosimilars can specifically assess their immunogenicity, their extrapolation to one or more conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascef, Bruna de Oliveira, Lopes, Ana Carolina de Freitas, de Soárez, Patrícia Coelho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448328/
https://www.ncbi.nlm.nih.gov/pubmed/32843051
http://dx.doi.org/10.1186/s12961-020-00611-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448328/
https://www.ncbi.nlm.nih.gov/pubmed/32843051
http://dx.doi.org/10.1186/s12961-020-00611-y

Ejemplares similares